Latus Bio
Latus Bio is developing curative AAV gene therapy products for CNS disorders
Source-backed public directory
Explore 3 Therapeutics portfolio companies with source-backed publicly reported investor directories. Each listing is evidence-based and may not be complete.
Latus Bio is developing curative AAV gene therapy products for CNS disorders
Gene Therapy for Longevity, Performance & Wellness
angel investor
Bioengineered therapies for Kidney Disease